论文部分内容阅读
肺癌病人手术、化疗、放疗等总的５年生存率还不令人满意 ,探索治疗肺癌的新方法和新技术仍是十分迫切的课题。介入治疗已从原来单一的介入放射治疗向其他各个方面发展。包括血管性介入治疗 :支气管动脉介入、肺动脉介入和支气管动脉、肺动脉双介入治疗 ;腔内介入治疗 :包括胸
The overall 5-year survival rate of patients with lung cancer such as surgery, chemotherapy and radiotherapy is still not satisfactory. It is still an urgent issue to explore new methods and new technologies for the treatment of lung cancer. Interventional therapy has evolved from a single interventional radiotherapy to other aspects. Including vascular interventional therapy: bronchial artery intervention, pulmonary artery intervention and bronchial artery, pulmonary artery dual interventional treatment; endovascular interventional treatment: including chest